Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by JLGeminion Feb 25, 2011 12:23pm
255 Views
Post# 18194472

RE: RE: Anybody know when a phase III trial is exp

RE: RE: Anybody know when a phase III trial is expAs an investor, I want to know why Oncolytics stock performance is below its 52 week high and why it is below where it closed on Dec 31, 2010.  News has been released and the US NCI has further endorsed Reolysin to justify an increase in stock price.  Don't give me this BS of Brad not informing shareholders.

A deceitful group wants to buy shares, without the use of margin, by bad mouthing the company and the CEO to lower the price.  They also take advantage of their purchasing advantage by managing the stock price using dirty tricks.

Get my drift #$443#!  Every coach wants a whiner like you on their team.  It's good for morale. (Sarcasm)  Owns since 2003.  Starts whining in 2011.  LOL, I do not think that you are a seller.  You are a buyer. 

Christmas is coming.  I have not started shopping for it yet.  I’m expecting news on ONC trials and partnership agreements any day now until mid year.  I have my big position in place but want to buy more shares on the price advance below $10.  Some fund managers are going to be in a rush to accumulate their position in time for the big move.  They will put more pressure on the manipulation.  I don't feel sorry for the holders of the 2.5 million short shares.  The effect of their short selling to depress the price is over and reflected in the current valuation.  They have either kissed a potential gain away by having existing holdings to cover a call or will add big time to the upward pricing pressure when a call is made.
Bullboard Posts